Leu27 insulin-like growth factor-II, an insulin-like growth factor-II analog, attenuates depolarization-evoked GABA release from adult rat hippocampal and cortical slices

Neuroscience

Volumn 170, Issue 3, 2010, Pages 722-730

  Amritraj, A ^a   Rauw, G ^a   Baker, G B ^a   Kar, S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

IGF II receptor; Neurotransmitter release; Pertussis toxin; Receptor immunohistochemistry; Tetrodotoxin

Indexed keywords

4 AMINOBUTYRIC ACID; PERTUSSIS TOXIN; POTASSIUM ION; SOMATOMEDIN B; SOMATOMEDIN B LEU 27; SOMATOMEDIN B RECEPTOR; TETRODOTOXIN; UNCLASSIFIED DRUG; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL; DRUG DERIVATIVE; INSULIN LIKE GROWTH FACTOR II, LEU(27); INSULIN-LIKE GROWTH FACTOR II, LEU(27)-; POTASSIUM;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPOLARIZATION; FRONTAL CORTEX; GABAERGIC SYSTEM; HIPPOCAMPUS; MALE; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; RECEPTOR BINDING; ANIMAL; BRAIN CORTEX; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR II; MALE; PERTUSSIS TOXIN; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 2; SIGNAL TRANSDUCTION; TETRODOTOXIN; VERATRIDINE;

EID: 79952116390     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.07.026     Document Type: Article

References (63)

1. Amritraj A., Hawkes C., Phinney A.L., Mount T.H., Scott C.D., Westaway D., Kar S. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP+PS1 transgenic mouse brains. Neurobiol Aging 2009, 30:54-70.
2. Araujo D.M., Lapchak P.A., Collier B., Chabot J.G., Quirion R. Insulin-like growth factor-I (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res 1989, 484:130-138.
3. Beilharz E.J., Bassett N.S., Sirimanne E.S., Williams C.E., Gluckman P.D. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol Brain Res 1995, 29:81-91.
4. Breese C.R., D'Costa A., Rollins Y.D., Adams C., Booze R.M., Sonntag W.E., Leonard S. Expression of insulin-like growth factor-1 (IGF-1) and IGF-binding protein 2 (IGF-bp2) in the hippocampus following cytotoxic lesion of the dentate gyrus. J Comp Neurol 1996, 369:388-404.
5. Celio M.R. Parvalbumin in most gamma-aminobutyric acid containing neurons of the rat cerebral cortex. Science 1986, 231:995-997.
6. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 1992, 12:1558-1566.
7. Chu C.H., Tzang B.S., Chen L.M., Liu C.J., Tsai F.J., Tsai C.H., Lin J.A., Kuo W.W., Bau D.T., Yao C.H., Huang C.Y. Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through Gαq and downstream calcineurin signaling in myocardial cells. Endocrinology 2009, 150:2723-2731.
8. Cortez M.A., Wu Y., Gibson K.M., Snead O.C. Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy. Pharmacol Biochem Behav 2004, 79:547-553.
9. Couce M., Weatherington A., McGinty J.F. Expression of insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptor in the rat hippocampus: an in situ hybridization and immunocytochemical study. Endocrinology 1992, 131:1636-1642.
10. Cowan R.L., Wilson C.J., Emson P.C., Heizmann C.W. Parvalbumin-containing GABAergic interneurons in the rat neostraitum. J Comp Neurol 1990, 302:197-205.
11. Dahms N.M., Hancock M.K. P-type lectins. Biochim Biophys Acta 2002, 1572:317-340.
12. Davies C.H., Starkey S.J., Pozza M.F., Collingridge G.L. GABA autoreceptors regulate the induction of LTP. Nature 1991, 349:609-611.
13. Dikkes P., Hawkes C., Kar S., Lopez M.F. Effect of kainic acid treatment on insulin-like growth factor-2 receptors in the IGF2-deficient adult. Brain Res 2007, 1131:77-87.
14. Dore S., Kar S., Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997, 20:326-331.
15. El-Shewy H.M., Luttrell L.M. Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm 2009, 80:667-697.
16. Frasca F., Pandini G., Scalia P., Sciacca L., Mineo R., Costantino A., Goldfine I.D., Belfiore A., Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999, 19:3278-3288.
17. Froestl W., Gallagher M., Jenkins H., Madrid A., Melcher T., Teichman S., Mondadori C.G., Pearlman R. SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol 2004, 68:1479-1487.
18. Gage S.L., Keim S.R., Low W.C. Effects of insulin-like growth factor-II (IGF-II) on transplanted cholinergic neurons from the fetal septal nucleus. Prog Brain Res 1990, 82:73-80.
19. Ghoneim M.M., Block R.I., Ping S.T., el-Zahaby H.M., Hinrichs J.V. The interactions of midazolam and flumazenil on human memory and cognition. Anesthesiology 1993, 79:1183-1192.
20. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 2003, 4:202-212.
21. Guan J., Williams C.E., Skinner S.J., Mallard E.C., Gluckman P.D. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 1996, 137:893-898.
22. Hari J., Pierce S., Morgan D., Sara V., Smith M., Roth R. The receptor for insulin-like growth factor-II mediates an insulin-like response. EMBO J 1987, 6:3367-3371.
23. Hawkes C., Amritraj A., MacDonald R.G., Jhamandas J.H., Kar S. Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling. Mol Neurobiol 2007, 35:329-345.
24. Hawkes C., Jhamandas J.H., Harris K.H., Fu W., MacDonald R.G., Kar S. Single transmembrane domain insulin-like growth factor-II/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway. J Neurosci 2006, 26:585-596.
25. Hawkes C., Kar S. Insulin-like growth factor-II/mannose-6-phosphate receptor: widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype. J Comp Neurol 2003, 458:113-127.
26. Hawkes C., Kar S. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res Rev 2004, 44:117-140.
27. Hille-Rehfeld A. Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta 1995, 1241:177-194.
28. Ikezu T., Okamoto T., Giambarella U., Yokota T., Nishimoto I. In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor. J Biol Chem 1995, 270:29224-29228.
29. Jafferali S., Dumont Y., Sotty F., Robitaille Y., Quirion R., Kar S. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus and cerebellum of normal human and Alzheimer's disease brains. Synapse 2000, 38:450-459.
30. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.
31. Kabogo D., Rauw G., Amritraj A., Baker G., Kar S. β-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices. Neurobiol Aging 2010, 31:1164-1172.
32. Kar S., Chabot J.G., Quirion R. Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol 1993, 333:375-397.
33. Kar S., Baccichet A., Quirion R., Poirier J. Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience 1993, 55:69-80.
34. Kar S., Seto D., Doré S., Hanisch U.K., Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the hippocampal formation. Proc Natl Acad Sci U S A 1997, 94:14054-14059.
35. Kar S., Seto D., Gaudreau P., Quirion R. β-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal formation. J Neurosci 1996, 16:1034-1040.
36. Konishi T., Takahashi K., Chui D.H., Rosenfeld R., Himeno M., Tabira T. Insulin-like growth factor II promotes in vitro cholinergic development of mouse septal neurons: comparison with the effects of insulin-like growth factor I. Brain Res 1994, 649:53-61.
37. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res 1987, 419:119-130.
38. Lee W.H., Clemens J.A., Bondy C.A. Insulin-like growth factors in response to cerebral ischemia. Mol Cell Neurosci 1992, 3:36-43.
39. Lesniak M., Hill J., Kiess W., Rojeski M., Pert C., Roth J. Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 1988, 123:2089-2099.
40. MacDonald R.G. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes. Endocrinology 1991, 128:413-421.
41. Matsunaga H., Nishimoto I., Kojima I., Yamashita N., Kurokawa K., Ogata E. Activation of a calcium-permeable cation channel by insulin-like growth factor-II in BALB/c 3T3 cells. Am J Physiol 1988, 255:C442-C446.
42. McKinnon T., Chakraborty C., Gleeson L.M., Chidiac P., Lala P.K. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001, 86:3665-3674.
43. Minniti C.P., Kohn E.C., Grubb J.H., Sly W.S., Oh Y., Muller H.L., Rosenfeld R.G., Helman L.J. The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem 1992, 267:9000-9004.
44. B receptor antagonist CGP36,742 and nootropic oxiracetam facilitate the formation of long term memory. Behav Brain Res 1996, 77:223-225.
45. Morgan D.O., Edman J.C., Standring D.N., Fried V.A., Smith M.C., Roth R.A., Rutter W.J. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987, 329:301-307.
46. B receptor. Science 1991, 252:1718-1720.
47. Murayama Y., Okamoto T., Ogata E., Asano T., Iiri T., Katada T., Ui M., Grubb J.H., Sly W.S., Nishimoto I. Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate. J Biol Chem 1990, 265:17456-17462.
48. Napoli I., Blusztajn J.K., Mellot T.J. Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex. Brain Res 2008, 1237:124-135.
49. Narahashi T. Chemicals as tools in the study of excitable membranes. Physiol Rev 1974, 54:813-889.
50. Parent M., Bush D., Rauw G., Master S., Vaccarino F., Baker G. Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods 2001, 23:11-20.
51. +-evoked release of acetylcholine from rat brain synaptosomes: analysis by rapid superfusion. J Neurochem 1991, 57:636-647.
52. Rogers S.A., Purchio A.F., Hammerman M.R. Mannose 6-phosphate-containing peptides activate phospholipase C in proximal tubular basolateral membranes from canine kidney. J Biol Chem 1990, 265:9722-9727.
53. Rosenthal S.M., Hsiao D., Silverman L.A. An insulin-like growth factor-II (IGF-II) analog with highly selective affinity for IGF-II receptors stimulates differentiation, but not IGF-I receptor down-regulation in muscle cells. Endocrinology 1994, 135:38-44.
54. Sahu A., Dube M.G., Phelps C.P., Sninsky C.A., Kalra P.S., Kalra S.P. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 1995, 136:5718-5724.
55. Seto D., Zheng W.H., McNicoll A., Collier B., Quirion R., Kar S. Involvement of GABA in insulin-like growth factor-I mediated inhibition of acetylcholine release from rat hippocampal formation. Neuroscience 2002, 115:603-612.
56. Shimizu M., Webster C., Morgan D., Blau H., Roth R. Insulin and insulin-like growth factor receptors and responses in cultured human muscle cells. Am J Physiol 1986, 215:E611-E615.
57. Silva A., Montague J., Lopez T., Mudd L. Growth factor effects on survival and development of calbindin immunopositive cultured septal neurons. Brain Res Bull 2000, 51:35-42.
58. B receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS. J Neurosci 1999, 19:4609-4615.
59. Stephenson D., Rash K., Clemens J. Increase in insulin-like growth factor II receptor within ischemic neurons following cerebral infarction. J Cereb Blood Flow Metab 1995, 15:1022-1031.
60. Walter H.J., Berry M., Hill D.J., Cwyfan-Hughes S., Holly J.M., Logan A. Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: possible roles of IGF binding proteins (IGFBPs) in the mediation of IGF-II activity. Endocrinology 1999, 140:520-532.
61. Yamane H.K., Fung B.K. Covalent modifications of G-proteins. Annu Rev Pharmacol Toxicol 1993, 33:201-241.
62. B receptors in mammalian brain: potential targets for drug development. Drug Dev Res 1990, 21:161-167.
63. Zhang Q., Tally M., Larsson O., Kennedy R., Huang L., Hall K., Berggren P.O. Insulin-like growth factor-II signaling through the insulin-like growth factor-II/mannose 6-phosphate receptor promotes exocytosis of insulin-secreting cells. Proc Natl Acad Sci U S A 1997, 94:6232-6236.